Across TCGA pan-cancer cohorts, DBIP1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of DBIP1’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where DBIP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DBIP1 is over-expressed in tumor, although a few such as LIHC show the opposite, repressed pattern.

UCEC, COAD, and BLCA are the cancer types where DBIP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DBIP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	III,IV	+0.320	.007	6	view →
COAD	All	II,III,IV	+0.765	<.001	5	view →
BLCA	All	All	+0.156	.007	5	view →
THCA	All	II,III,IV	+0.090	.023	2	view →
LIHC	Female	All	−0.127	.005	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: DBIP1 RNA expression & survival · all DBIP1 data types